Global Monoclonal Antibody Therapeutics Market 2017 by Top Manufacturers, Growth Rate, Key Trends, Size, Share, Forecast to 2022

Request for a SAMPLE REPORT

Fill up your details below and get the sample report for FREE

 Published Date : Sep-2017   |    Format :PDF   |    Number of Pages : 106
This report studies the global Monoclonal Antibody Therapeutics market, analyzes and researches the Monoclonal Antibody Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
    Bayer
    F. Hoffmann-La Roche
    Pfizer
    Sanofi
    GlaxoSmithKline
    Merck
    Novartis
    AbbVie
    Amgen
    Johnson & Johnson
    Bristol-Myers Squibb Company
    Biogen

Market segment by Regions/Countries, this report covers
    United States
    EU
    Japan
    China
    India
    Southeast Asia

Market segment by Type, Monoclonal Antibody Therapeutics can be split into
    Humanized Antibody
    Human Mouse Chimeric Antibody

Market segment by Application, Monoclonal Antibody Therapeutics can be split into
    Cancer
    Autoimmune Diseases
    Infection
    Hematological Diseases
    Ophthalmological Diseases
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Monoclonal Antibody Therapeutics Market Size, Status and Forecast 2022
1 Industry Overview of Monoclonal Antibody Therapeutics
    1.1  Monoclonal Antibody Therapeutics Market Overview
        1.1.1 Monoclonal Antibody Therapeutics Product Scope
        1.1.2 Market Status and Outlook
    1.2 Global Monoclonal Antibody Therapeutics Market Size and Analysis by Regions
        1.2.1 United States
        1.2.2 EU
        1.2.3 Japan
        1.2.4 China
        1.2.5 India
        1.2.6 Southeast Asia
    1.3 Monoclonal Antibody Therapeutics Market by Type
        1.3.1 Humanized Antibody
        1.3.2 Human Mouse Chimeric Antibody
    1.4 Monoclonal Antibody Therapeutics Market by End Users/Application
        1.4.1 Cancer
        1.4.2 Autoimmune Diseases
        1.4.3 Infection
        1.4.4 Hematological Diseases
        1.4.5 Ophthalmological Diseases
        1.4.6 Others

2 Global Monoclonal Antibody Therapeutics Competition Analysis by Players
    2.1 Monoclonal Antibody Therapeutics Market Size (Value) by Players (2016 and 2017)
    2.2 Competitive Status and Trend
        2.2.1 Market Concentration Rate
        2.2.2 Product/Service Differences
        2.2.3 New Entrants
        2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
    3.1 Bayer
        3.1.1 Company Profile
        3.1.2 Main Business/Business Overview
        3.1.3 Products, Services and Solutions
        3.1.4 Monoclonal Antibody Therapeutics Revenue (Value) (2012-2017)
        3.1.5 Recent Developments
    3.2 F. Hoffmann-La Roche
        3.2.1 Company Profile
        3.2.2 Main Business/Business Overview
        3.2.3 Products, Services and Solutions
        3.2.4 Monoclonal Antibody Therapeutics Revenue (Value) (2012-2017)
        3.2.5 Recent Developments
    3.3 Pfizer
        3.3.1 Company Profile
        3.3.2 Main Business/Business Overview
        3.3.3 Products, Services and Solutions
        3.3.4 Monoclonal Antibody Therapeutics Revenue (Value) (2012-2017)
        3.3.5 Recent Developments
    3.4 Sanofi
        3.4.1 Company Profile
        3.4.2 Main Business/Business Overview
        3.4.3 Products, Services and Solutions
        3.4.4 Monoclonal Antibody Therapeutics Revenue (Value) (2012-2017)
        3.4.5 Recent Developments
    3.5 GlaxoSmithKline
        3.5.1 Company Profile
        3.5.2 Main Business/Business Overview
        3.5.3 Products, Services and Solutions
        3.5.4 Monoclonal Antibody Therapeutics Revenue (Value) (2012-2017)
        3.5.5 Recent Developments
    3.6 Merck
        3.6.1 Company Profile
        3.6.2 Main Business/Business Overview
        3.6.3 Products, Services and Solutions
        3.6.4 Monoclonal Antibody Therapeutics Revenue (Value) (2012-2017)
        3.6.5 Recent Developments
    3.7 Novartis
        3.7.1 Company Profile
        3.7.2 Main Business/Business Overview
        3.7.3 Products, Services and Solutions
        3.7.4 Monoclonal Antibody Therapeutics Revenue (Value) (2012-2017)
        3.7.5 Recent Developments
    3.8 AbbVie
        3.8.1 Company Profile
        3.8.2 Main Business/Business Overview
        3.8.3 Products, Services and Solutions
        3.8.4 Monoclonal Antibody Therapeutics Revenue (Value) (2012-2017)
        3.8.5 Recent Developments
    3.9 Amgen
        3.9.1 Company Profile
        3.9.2 Main Business/Business Overview
        3.9.3 Products, Services and Solutions
        3.9.4 Monoclonal Antibody Therapeutics Revenue (Value) (2012-2017)
        3.9.5 Recent Developments
    3.10 Johnson & Johnson
        3.10.1 Company Profile
        3.10.2 Main Business/Business Overview
        3.10.3 Products, Services and Solutions
        3.10.4 Monoclonal Antibody Therapeutics Revenue (Value) (2012-2017)
        3.10.5 Recent Developments
    3.11 Bristol-Myers Squibb Company
    3.12 Biogen

4 Global Monoclonal Antibody Therapeutics Market Size by Type and Application (2012-2017)
    4.1 Global Monoclonal Antibody Therapeutics Market Size by Type (2012-2017)
    4.2 Global Monoclonal Antibody Therapeutics Market Size by Application (2012-2017)
    4.3 Potential Application of Monoclonal Antibody Therapeutics in Future
    4.4 Top Consumer/End Users of Monoclonal Antibody Therapeutics

5 United States Monoclonal Antibody Therapeutics Development Status and Outlook
    5.1 United States Monoclonal Antibody Therapeutics Market Size (2012-2017)
    5.2 United States Monoclonal Antibody Therapeutics Market Size and Market Share by Players (2016 and 2017)

6 EU Monoclonal Antibody Therapeutics Development Status and Outlook
    6.1 EU Monoclonal Antibody Therapeutics Market Size (2012-2017)
    6.2 EU Monoclonal Antibody Therapeutics Market Size and Market Share by Players (2016 and 2017)

7 Japan Monoclonal Antibody Therapeutics Development Status and Outlook
    7.1 Japan Monoclonal Antibody Therapeutics Market Size (2012-2017)
    7.2 Japan Monoclonal Antibody Therapeutics Market Size and Market Share by Players (2016 and 2017)

8 China Monoclonal Antibody Therapeutics Development Status and Outlook
    8.1 China Monoclonal Antibody Therapeutics Market Size (2012-2017)
    8.2 China Monoclonal Antibody Therapeutics Market Size and Market Share by Players (2016 and 2017)

9 India Monoclonal Antibody Therapeutics Development Status and Outlook
    9.1 India Monoclonal Antibody Therapeutics Market Size (2012-2017)
    9.2 India Monoclonal Antibody Therapeutics Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Monoclonal Antibody Therapeutics Development Status and Outlook
    10.1 Southeast Asia Monoclonal Antibody Therapeutics Market Size (2012-2017)
    10.2 Southeast Asia Monoclonal Antibody Therapeutics Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
    11.1 Global Monoclonal Antibody Therapeutics Market Size (Value) by Regions (2017-2022)
        11.1.1 United States Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2022)
        11.1.2 EU Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2022)
        11.1.3 Japan Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2022)
        11.1.4 China Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2022)
        11.1.5 India Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2022)
        11.1.6 Southeast Asia Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2022)
    11.2 Global Monoclonal Antibody Therapeutics Market Size (Value) by Type (2017-2022)
    11.3 Global Monoclonal Antibody Therapeutics Market Size by Application (2017-2022)

12 Monoclonal Antibody Therapeutics Market Dynamics
    12.1 Monoclonal Antibody Therapeutics Market Opportunities
    12.2 Monoclonal Antibody Therapeutics Challenge and Risk
        12.2.1 Competition from Opponents
        12.2.2 Downside Risks of Economy
    12.3 Monoclonal Antibody Therapeutics Market Constraints and Threat
        12.3.1 Threat from Substitute
        12.3.2 Government Policy
        12.3.3 Technology Risks
    12.4 Monoclonal Antibody Therapeutics Market Driving Force
        12.4.1 Growing Demand from Emerging Markets
        12.4.2 Potential Application

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs Trend/Customer Preference
    13.3 External Environmental Change
        13.3.1 Economic Fluctuations
        13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
    Methodology
    Analyst Introduction
    Data Source


List of Tables and Figures

    Figure Monoclonal Antibody Therapeutics Product Scope
    Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) (2012-2017)
    Table Global Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure Global Monoclonal Antibody Therapeutics Market Share by Regions in 2016
    Figure United States Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure EU Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure Japan Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure China Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure India Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure Southeast Asia Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure Global Monoclonal Antibody Therapeutics Market Share by Type in 2016
    Figure Humanized Antibody Market Size (Million USD) and Growth Rate (2012-2017)
    Figure Human Mouse Chimeric Antibody Market Size (Million USD) and Growth Rate (2012-2017)
    Figure Global Monoclonal Antibody Therapeutics Market Share by Application in 2016
    Table Key Downstream Customer in Cancer
    Figure Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate in Cancer (2012-2017)
    Table Key Downstream Customer in Autoimmune Diseases
    Figure Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate in Autoimmune Diseases (2012-2017)
    Table Key Downstream Customer in Infection
    Figure Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate in Infection (2012-2017)
    Table Key Downstream Customer in Hematological Diseases
    Figure Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate in Hematological Diseases (2012-2017)
    Table Key Downstream Customer in Ophthalmological Diseases
    Figure Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate in Ophthalmological Diseases (2012-2017)
    Table Key Downstream Customer in Others
    Figure Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate in Others (2012-2017)
    Table Monoclonal Antibody Therapeutics Market Size (Million USD) by Players (2016 and 2017)
    Figure Monoclonal Antibody Therapeutics Market Size Share by Players in 2016
    Figure Monoclonal Antibody Therapeutics Market Size Share by Players in 2017
    Table Bayer Basic Information List
    Table Monoclonal Antibody Therapeutics Business Revenue (Million USD) of Bayer (2012-2017)
    Figure Bayer Monoclonal Antibody Therapeutics Business Revenue Market Share in 2016
    Table F. Hoffmann-La Roche Basic Information List
    Table Monoclonal Antibody Therapeutics Business Revenue (Million USD) of F. Hoffmann-La Roche (2012-2017)
    Figure F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Business Revenue Market Share in 2016
    Table Pfizer Basic Information List
    Table Monoclonal Antibody Therapeutics Business Revenue (Million USD) of Pfizer (2012-2017)
    Figure Pfizer Monoclonal Antibody Therapeutics Business Revenue Market Share in 2016
    Table Sanofi Basic Information List
    Table Monoclonal Antibody Therapeutics Business Revenue (Million USD) of Sanofi (2012-2017)
    Figure Sanofi Monoclonal Antibody Therapeutics Business Revenue Market Share in 2016
    Table GlaxoSmithKline Basic Information List
    Table Monoclonal Antibody Therapeutics Business Revenue (Million USD) of GlaxoSmithKline (2012-2017)
    Figure GlaxoSmithKline Monoclonal Antibody Therapeutics Business Revenue Market Share in 2016
    Table Merck Basic Information List
    Table Monoclonal Antibody Therapeutics Business Revenue (Million USD) of Merck (2012-2017)
    Figure Merck Monoclonal Antibody Therapeutics Business Revenue Market Share in 2016
    Table Novartis Basic Information List
    Table Monoclonal Antibody Therapeutics Business Revenue (Million USD) of Novartis (2012-2017)
    Figure Novartis Monoclonal Antibody Therapeutics Business Revenue Market Share in 2016
    Table AbbVie Basic Information List
    Table Monoclonal Antibody Therapeutics Business Revenue (Million USD) of AbbVie (2012-2017)
    Figure AbbVie Monoclonal Antibody Therapeutics Business Revenue Market Share in 2016
    Table Amgen Basic Information List
    Table Monoclonal Antibody Therapeutics Business Revenue (Million USD) of Amgen (2012-2017)
    Figure Amgen Monoclonal Antibody Therapeutics Business Revenue Market Share in 2016
    Table Johnson & Johnson Basic Information List
    Table Monoclonal Antibody Therapeutics Business Revenue (Million USD) of Johnson & Johnson (2012-2017)
    Figure Johnson & Johnson Monoclonal Antibody Therapeutics Business Revenue Market Share in 2016
    Table Bristol-Myers Squibb Company Basic Information List
    Table Monoclonal Antibody Therapeutics Business Revenue (Million USD) of Bristol-Myers Squibb Company (2012-2017)
    Figure Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Business Revenue Market Share in 2016
    Table Biogen Basic Information List
    Table Monoclonal Antibody Therapeutics Business Revenue (Million USD) of Biogen (2012-2017)
    Figure Biogen Monoclonal Antibody Therapeutics Business Revenue Market Share in 2016
    Table Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Type (2012-2017)
    Figure Global Monoclonal Antibody Therapeutics Market Size Share by Type in 2012
    Figure Global Monoclonal Antibody Therapeutics Market Size Share by Type in 2013
    Figure Global Monoclonal Antibody Therapeutics Market Size Share by Type in 2014
    Figure Global Monoclonal Antibody Therapeutics Market Size Share by Type in 2015
    Figure Global Monoclonal Antibody Therapeutics Market Size Share by Type in 2016
    Figure Global Monoclonal Antibody Therapeutics Market Size Share by Type in 2017
    Table Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Application (2012-2017)
    Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Application in 2012
    Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Application in 2013
    Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Application in 2014
    Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Application in 2015
    Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Application in 2016
    Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Application in 2017
    Table Top Consumer/End Users of Monoclonal Antibody Therapeutics
    Figure United States Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table United States Monoclonal Antibody Therapeutics Market Size (Million USD) by Players (2012-2017)
    Figure United States Monoclonal Antibody Therapeutics Market Size Share by Players in 2016
    Figure United States Monoclonal Antibody Therapeutics Market Size Share by Players in 2017
    Figure EU Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table EU Monoclonal Antibody Therapeutics Market Size (Million USD) by Players (2012-2017)
    Figure EU Monoclonal Antibody Therapeutics Market Size Share by Players in 2016
    Figure EU Monoclonal Antibody Therapeutics Market Size Share by Players in 2017
    Figure Japan Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table Japan Monoclonal Antibody Therapeutics Market Size (Million USD) by Players (2012-2017)
    Figure Japan Monoclonal Antibody Therapeutics Market Size Share by Players in 2016
    Figure Japan Monoclonal Antibody Therapeutics Market Size Share by Players in 2017
    Figure China Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table China Monoclonal Antibody Therapeutics Market Size (Million USD) by Players (2012-2017)
    Figure China Monoclonal Antibody Therapeutics Market Size Share by Players in 2016
    Figure China Monoclonal Antibody Therapeutics Market Size Share by Players in 2017
    Figure India Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table India Monoclonal Antibody Therapeutics Market Size (Million USD) by Players (2012-2017)
    Figure India Monoclonal Antibody Therapeutics Market Size Share by Players in 2016
    Figure India Monoclonal Antibody Therapeutics Market Size Share by Players in 2017
    Figure Southeast Asia Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table Southeast Asia Monoclonal Antibody Therapeutics Market Size (Million USD) by Players (2012-2017)
    Figure Southeast Asia Monoclonal Antibody Therapeutics Market Size Share by Players in 2016
    Figure Southeast Asia Monoclonal Antibody Therapeutics Market Size Share by Players in 2017
    Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Regions (2017-2022)
    Table Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Regions (2017-2022)
    Figure Global Monoclonal Antibody Therapeutics Market Size Share by Regions in 2017
    Figure Global Monoclonal Antibody Therapeutics Market Size Share by Regions in 2022
    Figure United States Monoclonal Antibody Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
    Figure EU Monoclonal Antibody Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
    Figure Japan Monoclonal Antibody Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
    Figure China Monoclonal Antibody Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
    Figure India Monoclonal Antibody Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
    Figure Southeast Asia Monoclonal Antibody Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
    Table Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Type (2017-2022)
    Figure Global Monoclonal Antibody Therapeutics Market Size Share by Type in 2017
    Figure Global Monoclonal Antibody Therapeutics Market Size Share by Type in 2022
    Table Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Application (2017-2022)
    Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Application in 2017
    Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Application in 2022



Latest News

25-Feb-2019 | Medical Devices

Launch Of Symjepi Epinephrine Syringe To Boost The Syringe Market Growth In US

A rising burden of chronic diseases has been observed all across the world, which, in turn, has elevated the usage of syringes. Overall, the global syringe market is anticipated to observe vigorous ...

25-Feb-2019 | Electrical & Electronic Device

Launch Of Xiaomi Set-Top Box To Power The Global 4K Set-Top Box Market

While smart TVs are turning out to be much more widespread these days, a number of consumers still choose to opt for normal TVs and then employ smart streaming set top box with them. Popular choice ...

13-Feb-2019 | Software

Bioinspired Artificial Bug Eye Creation Is A Baton For Global Autonomous Car Market

After looking at the different eye lens structures of the animals and humans, the researchers have decided on creating a sharp image using its design. The compound eyes of the bugs are currently be ...

13-Feb-2019 | Consumer Goods & Retailing

Cafe X’s $12 Million “Seed-1” Round To Boost The Global Coffee Market

Cafe X, a company engaged in building robot baristas, is about to raise a $12 Million “Seed-1” round. Recently, Crunchbase News broke the story when it came across regulatory f ...

05-Feb-2019 | Chemicals & Materials

Clinically Produced Cells Change The Horizon Of Global Bone Cement And Glue Market

The group of researchers from the New York Stem Cell Foundation Research Institute published an article in Stem Cell Research and Therapy where the details regarding the clinical ...